Department of Quality and Health Technologies, University of Stavanger Faculty of Health Sciences, Stavanger, Norway
Research Department, Research Group of Nursing and Health Sciences, Stavanger University Hospital, Stavanger, Norway.
BMJ Open. 2023 Aug 3;13(8):e069599. doi: 10.1136/bmjopen-2022-069599.
A growing number of patients with non-communicable diseases (NCDs), such as heart failure (HF) and colorectal cancer (CRC), are prone to comorbidity, a high rate of readmissions and complex healthcare needs. An eHealth intervention, however, could potentially ameliorate the increasing burdens associated with NCDs by helping to smoothen patient transition from hospital to home and by reducing the number of readmissions. This feasibility study therefore aims to assess the feasibility of a nurse-assisted eHealth intervention posthospital discharge among patients with HF and CRC, while also examining the preliminary clinical and behavioural outcomes of the intervention before initiating a full-scale randomised controlled trial. The recruitment ended in January 2023.
Twenty adult patients with HF and 10 adult patients with CRC will be recruited from two university hospitals in Norway. Six hospital-based nurse navigators (NNs) will offer support during the transition phase from hospital to home by using a solution for digital remote care, Dignio Connected Care. The patients will use the MyDignio application uploaded to an iPad for 30 days postdischarge. The interactions between patients and NNs will then be assessed through direct observation and qualitative interviews in line with a think-aloud protocol. Following the intervention, semistructured interviews will be used to explore patients' experiences of eHealth support and NNs' experiences of eHealth delivery. The feasibility testing will also comprise a post-test of the Post-System Usability Questionnaire and pretesting of patient-reported outcomes questionnaires, as well as an inspection of user data collected from the software.
The study has been approved by the Norwegian Centre for Research Data (ID.NO: 523386). All participation is based on informed, written consent. The results of the study will be published in open-access, peer-reviewed journals and presented at international and national scientific conferences and meetings.
越来越多患有非传染性疾病(NCDs)的患者,如心力衰竭(HF)和结直肠癌(CRC),容易合并症,再入院率高,医疗需求复杂。然而,电子健康干预可能通过帮助患者平稳地从医院过渡到家庭,并减少再入院的次数,从而缓解与 NCD 相关的不断增加的负担。因此,这项可行性研究旨在评估在 HF 和 CRC 患者出院后,由护士协助的电子健康干预的可行性,同时在启动全面随机对照试验之前,检查干预的初步临床和行为结果。招募工作已于 2023 年 1 月结束。
将从挪威的两家大学医院招募 20 名 HF 成年患者和 10 名 CRC 成年患者。6 名医院护士导航员(NN)将通过使用数字远程护理解决方案 Dignio Connected Care 在从医院到家庭的过渡阶段提供支持。患者将在出院后 30 天内使用上传到 iPad 的 MyDignio 应用程序。然后,将通过直接观察和基于“思考 aloud”协议的定性访谈评估患者和 NN 之间的互动。干预结束后,将使用半结构化访谈来探索患者对电子健康支持的体验和 NN 对电子健康提供的体验。可行性测试还将包括对 Post-System Usability Questionnaire 的后测、对患者报告结局问卷的预测试,以及对软件收集的用户数据的检查。
该研究已获得挪威研究数据中心(ID.NO:523386)的批准。所有参与都是基于知情的书面同意。研究结果将在开放获取的同行评议期刊上发表,并在国际和国家科学会议和会议上展示。